Comparative analysis of the anti-tumor activity and mechanism of action of TARA-002 and BCG in bladder cancer models. Cox proportional hazards regression model in patients with non-urothelial MIBC.

Notably, treatment usage trends from a Bladder Cancer Advocacy Network (BCAN) survey presented at GU ASCO 2025 revealed that only 1–5% of patients reported having seen a radiation oncologist and only ...

Impact of trimodal therapy on survival outcomes in non-urothelial muscle-invasive bladder cancer: A nationwide analysis.

Dr. Moschini proposed treatment with neoadjuvant chemotherapy followed by radical cystectomy or trimodal therapy. Dr. Choudhury described this patient as “perfect for bladder preservation” on the ...

Imfinzi plus BCG therapy significantly improved DFS in high-risk NMIBC patients compared to BCG alone, as shown in the POTOMAC phase 3 trial. The trial was not statistically powered for overall ...

Based on these outcomes, investigators shared that this personalized vaccine approach demonstrated feasibility for both individuals with metastatic bladder cancer, as well as patients undergoing ...

AstraZeneca aims to widen the pool of bladder cancer patients who can be treated ... induction and maintenance therapy—experienced a statistically significant and clinically meaningful ...

(Alliance News) - AstraZeneca PLC on Friday said it has received positive data from a trial evaluating Imfinzi as a treatment for patients with high-risk non-muscle-invasive bladder cancer.

induction and maintenance therapy, showed disease-free survival (DFS) improvement in individuals with high-risk non-muscle-invasive bladder cancer (NMIBC) in the POTOMAC Phase III trial.

Despite its usage, the precise mechanisms underlying androgen receptor pathway inhibitors therapy failure and the progression of prostate cancer remain unclear. Lead investigator Jan Bouchal ...

The HER2-targeted antibody-drug conjugate that Pfizer gained from its Seagen buyout has delivered positive results in a pivotal study among Chinese patients with newly diagnosed bladder cancer ...